Home - Products - Apoptosis - TNF - Ragifilimab

Ragifilimab

CAS No. 2207590-51-8

Ragifilimab( —— )

Catalog No. M36831 CAS No. 2207590-51-8

Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody that targets glucocorticoid-induced TNFR-associated protein (GITR) and can be used in the study of advanced or metastatic solid tumors.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	211	Get Quote
5MG	330	Get Quote
10MG	543	Get Quote
25MG	845	Get Quote
50MG	1150	Get Quote
100MG	1521	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ragifilimab
Note

Research use only, not for human use.
Brief Description

Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody that targets glucocorticoid-induced TNFR-associated protein (GITR) and can be used in the study of advanced or metastatic solid tumors.
Description

Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Apoptosis
Target

TNF
Recptor

TNF
Research Area

——
Indication

——

Chemical Information

CAS Number

2207590-51-8
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Hernandez-Guerrero T, et al: Not Ready for Prime Time. Clin Cancer Res. 2022 Sep 15;28(18):3905-3907.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Conatumumab

Conatumumab (AMG 655) is a monoclonal agonist antibody targeting human death receptor 5 [DR5, TRAILR2] with a dissociation constant (Kd) of 1 nM for long DR5 and 0.8 nM for short DR5.
XYLOBIOSE

XYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.
Dihydrodehydrodiconi...

Dihydrodehydrodiconiferyl alcohol is the methanolic extract of Liriodendron tulipifera.

Sign In Join Free